Bharat Biotech gets $15 mn upfront from Ocugen for rights to commercialise Covaxin in Canada Press Trust of India Jun 8, 2021 Ocugen has agreed to pay another $10 million to Bharat Biotech within a month from the commercial launch of Covaxin in Canada
